Synthetic post-translationally modified human A beta peptide exhibits a markedly increased tendency to form beta-pleated sheets in vitro - PubMed (original) (raw)

Synthetic post-translationally modified human A beta peptide exhibits a markedly increased tendency to form beta-pleated sheets in vitro

H Fabian et al. Eur J Biochem. 1994.

Free article

Abstract

The beta-amyloid peptide (A beta) is the major constituent of senile plaques, one of the hallmark neuropathological lesions of Alzheimer's disease. Recently a post-translationally modified analogue of the human beta-amyloid peptide, which contains isoaspartic residues in positions 1 and 7, was isolated from parenchyma and leptomeningeal microvasculature of Alzheimer's disease patients [Roher, A. E., Lowenson, JD., Clarke, S., Wolkow, C., Wang, R., Cotter, R. J., Reardon, I. M., Zürcher-Neely, H. A., Heinrikson, R. L., Ball, M. J. & Greenberg, B. D. (1993) J. Biol. Chem. 268, 3072-3083]. We used circular dichroism and Fourier-transform infrared spectroscopy to characterize the conformational changes on human A beta upon substitution of Asp1 and Asp7 to isoaspartic residues. We found that the intermolecular beta-pleated-sheet content is markedly increased for the post-translationally modified peptide compared to that in the corresponding unmodified human or rodent A beta sequences both in aqueous solutions in the pH 7-12 range, and in membrane-mimicking solvents (such as aqueous octyl-beta-D-glucoside or aqueous acetonitrile solutions). These findings underline the importance of the originally alpha-helical N-terminal regions of the unmodified A beta peptides in defining its secondary structure and may offer an explanation for the selective aggregation and retention of the isomerized A beta peptide in Alzheimer's-disease-affected brains.

PubMed Disclaimer

Cited by

Effect of Post-Translational Modifications and Mutations on Amyloid-β Fibrils Dynamics at N Terminus.
Vugmeyster L, Au DF, Ostrovsky D, Kierl B, Fu R, Hu ZW, Qiang W. Vugmeyster L, et al. Biophys J. 2019 Oct 15;117(8):1524-1535. doi: 10.1016/j.bpj.2019.09.004. Epub 2019 Sep 12. Biophys J. 2019. PMID: 31570231 Free PMC article.
Alzheimer's Aβ peptides with disease-associated N-terminal modifications: influence of isomerisation, truncation and mutation on Cu2+ coordination.
Drew SC, Masters CL, Barnham KJ. Drew SC, et al. PLoS One. 2010 Dec 30;5(12):e15875. doi: 10.1371/journal.pone.0015875. PLoS One. 2010. PMID: 21209855 Free PMC article.
Covalent structural changes in unfolded GroES that lead to amyloid fibril formation detected by NMR: insight into intrinsically disordered proteins.
Iwasa H, Meshitsuka S, Hongo K, Mizobata T, Kawata Y. Iwasa H, et al. J Biol Chem. 2011 Jun 17;286(24):21796-805. doi: 10.1074/jbc.M111.228445. Epub 2011 Apr 20. J Biol Chem. 2011. PMID: 21507961 Free PMC article.
Posttranslational arginylation of brain proteins.
Hallak ME, Bongiovanni G. Hallak ME, et al. Neurochem Res. 1997 Apr;22(4):467-73. doi: 10.1023/a:1027315912242. Neurochem Res. 1997. PMID: 9130258 Review.
Low levels of asparagine deamidation can have a dramatic effect on aggregation of amyloidogenic peptides: implications for the study of amyloid formation.
Nilsson MR, Driscoll M, Raleigh DP. Nilsson MR, et al. Protein Sci. 2002 Feb;11(2):342-9. doi: 10.1110/ps.48702. Protein Sci. 2002. PMID: 11790844 Free PMC article.

Synthetic post-translationally modified human A beta peptide exhibits a markedly increased tendency to form beta-pleated sheets in vitro - PubMed (original) (raw)